Altered expression of NLRP3 inflammasome in pediatric patients with primary immune thrombocytopenia and its relation to disease activity
- 21 November 2022
- journal article
- research article
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 32 (1) , 37-41
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopeniaThrombosis Research, 2019
- Pediatric ITP: is it different from adult ITP?Hematology-American Society Hematology Education Program, 2018
- NF-κB-94ins/del ATTG Genotype Contributes to the Susceptibility and Imbalanced Th17 Cells in Patients with Immune ThrombocytopeniaJournal of Immunology Research, 2018
- Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Journal of Clinical Medicine, 2017
- T cells in the pathogenesis of immune thrombocytopeniaSeminars in Hematology, 2016
- Molecular mechanisms regulating NLRP3 inflammasome activationCellular & Molecular Immunology, 2015
- Elevated expression of NLRP3 in patients with immune thrombocytopeniaImmunologic Research, 2015
- Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura PatientsInternational Journal of Biological Sciences, 2015
- Inflammasomes and host defenses against bacterial infectionsCurrent Opinion in Microbiology, 2013
- Regulation of adaptive immunity by the NLRP3 inflammasomeInternational Immunopharmacology, 2011